Reham F. Barghash is highly accomplished in the field of medicinal chemistry. Currently serving as a Prof. Dr. at Faculty of Biotechnology, MSA University. Dr. Barghash, received her Ph.D. degree in applied Organic Chemistry from Ain-Shams University, Cairo, Egypt, 2009 through Doctorate fellowship at Ferrara University, where she honed her skills and expertise in the intricate domain of chemical synthesis. Through several research grants, Dr Barghash got the opportunities to carry out her research work in Italy at Ferrara University, and postdoc at University of British Columbia‘s Okanagan Campus, Kelowna, BC, Canada. She was granted several awards; Best thesis NRC 2010, and NRC encouragement Award 2014. Dr Barghash has participated in national and international research projects for designing and developing pharmaceutical drugs as potential anticancer agents such as Breast, liver, leukemia cancer and potential antiviral agents such as COVID-19. She has actively participated in numerous national and international conferences, where she has presented her research findings and engaged in valuable scientific discussions. Moreover, she is a member of committees such as the Royal Society of Chemistry entitled Dr Reham Barghash MRSC, and International Organization for Women in Science for the Developing World (OWSD). Dr Barghash has published more than 30 papers and books in reputed international journals and has been serving as peerreviewer and editorial member of international journals. A large part, if not all, of her research interests in pharmaceutical and Medicinal chemistry and drug design is being developed with the aim of providing new products for biochemical studies and pharmaceutical and biomedical applications and drug design that specially target and combat various cancer types, where this work bridging the gap between laboratory discoveries and their potential application in clinical settings. Throughout her academic journey, Dr. Barghash has demonstrated exceptional research capabilities and a strong commitment to advancing the field of medicinal chemistry.
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.